View in EDS PDF Full Text

Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).

Saved in:
Bibliographic Details
Title: Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
Authors: Baran SW; Emerging Technologies, Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Brown PC; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Silver Spring, MD, USA., Baudy AR; ADME & Discovery Toxicology, Merck & Co., Inc., Kenilworth, NJ, USA., Fitzpatrick SC; U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of the Center Director, College Park, MD, USA., Frantz C; Translational Sciences, Seagen, Seattle, WA, USA., Fullerton A; Safety Assessment, Genentech, South San Francisco, CA, USA., Gan J; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, NJ, USA., Hardwick RN; Translational Safety Sciences, Theravance Biopharma US, Inc., South San Francisco, CA, USA., Hillgren KM; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA., Kopec AK; Drug Safety Research & Development, Pfizer, Inc., Groton, CT, USA., Liras JL; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Cambridge, MA, USA., Mendrick DL; U.S. Food and Drug Administration, National Center for Toxicological Research, Office of the Center Director, Silver Spring, MD, USA., Nagao R; Translational Sciences, Seagen, Seattle, WA, USA., Proctor WR; Safety Assessment, Genentech, South San Francisco, CA, USA., Ramsden D; Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., Cambridge, MA, USA., Ribeiro AJS; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Applied Regulatory Science, Silver Spring, MD, USA., Stresser D; Drug Metabolism, Pharmacokinetics and Bioanalysis, AbbVie, Inc., North Chicago, IL, USA., Sung KE; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Cellular and Gene Therapies, Silver Spring, MD, USA., Sura R; Global Preclinical Safety, AbbVie Inc., North Chicago, IL, USA., Tetsuka K; Analysis & Pharmacokinetics Research Labs., Astellas Pharma Inc., Tsukuba-shi, Ibaraki, Japan., Tomlinson L; Global Pathology, DSRD, Pfizer WRD, Cambridge, MA, USA., Van Vleet T; AbbVie, Inc., Chicago, IL, USA., Wagoner MP; Drug Safety Research & Evaluation, Takeda Pharmaceuticals International Co., Cambridge, MA, USA., Wang Q; Drug Safety Research & Evaluation, Takeda Pharmaceuticals International Co., Cambridge, MA, USA., Arslan SY; BioAnalysis, Applied Research Management & Biomedical Science (AMS), Astellas Pharma Inc., Northbrook, IL, USA., Yoder G; Aimmune (Nestlé Health Sciences), Brisbane, CA, USA., Ekert JE; In Vitro In Vivo Translation, Research, Pharmaceutical R&D, GlaxoSmithKline, Collegeville, PA, USA.
Source: ALTEX [ALTEX] 2022; Vol. 39 (2), pp. 297–314. Date of Electronic Publication: 2022 Jan 21.
Publication Type: Journal Article
Journal Info: Publisher: Spektrum Akademischer Verlag Country of Publication: Germany NLM ID: 100953980 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1868-8551 (Electronic) Linking ISSN: 1868596X NLM ISO Abbreviation: ALTEX Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35064273
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Baran+SW%22">Baran SW</searchLink>; Emerging Technologies, Novartis Institutes for BioMedical Research, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Brown+PC%22">Brown PC</searchLink>; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drugs, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Baudy+AR%22">Baudy AR</searchLink>; ADME & Discovery Toxicology, Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Fitzpatrick+SC%22">Fitzpatrick SC</searchLink>; U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of the Center Director, College Park, MD, USA.<br /><searchLink fieldCode="AU" term="%22Frantz+C%22">Frantz C</searchLink>; Translational Sciences, Seagen, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Fullerton+A%22">Fullerton A</searchLink>; Safety Assessment, Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gan+J%22">Gan J</searchLink>; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Hardwick+RN%22">Hardwick RN</searchLink>; Translational Safety Sciences, Theravance Biopharma US, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hillgren+KM%22">Hillgren KM</searchLink>; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Kopec+AK%22">Kopec AK</searchLink>; Drug Safety Research & Development, Pfizer, Inc., Groton, CT, USA.<br /><searchLink fieldCode="AU" term="%22Liras+JL%22">Liras JL</searchLink>; Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mendrick+DL%22">Mendrick DL</searchLink>; U.S. Food and Drug Administration, National Center for Toxicological Research, Office of the Center Director, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Nagao+R%22">Nagao R</searchLink>; Translational Sciences, Seagen, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Proctor+WR%22">Proctor WR</searchLink>; Safety Assessment, Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ramsden+D%22">Ramsden D</searchLink>; Global Drug Metabolism and Pharmacokinetics, Takeda Pharmaceuticals International Co., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ribeiro+AJS%22">Ribeiro AJS</searchLink>; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Applied Regulatory Science, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Stresser+D%22">Stresser D</searchLink>; Drug Metabolism, Pharmacokinetics and Bioanalysis, AbbVie, Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Sung+KE%22">Sung KE</searchLink>; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Tissues and Advanced Therapies, Division of Cellular and Gene Therapies, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sura+R%22">Sura R</searchLink>; Global Preclinical Safety, AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Tetsuka+K%22">Tetsuka K</searchLink>; Analysis & Pharmacokinetics Research Labs., Astellas Pharma Inc., Tsukuba-shi, Ibaraki, Japan.<br /><searchLink fieldCode="AU" term="%22Tomlinson+L%22">Tomlinson L</searchLink>; Global Pathology, DSRD, Pfizer WRD, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Van+Vleet+T%22">Van Vleet T</searchLink>; AbbVie, Inc., Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Wagoner+MP%22">Wagoner MP</searchLink>; Drug Safety Research & Evaluation, Takeda Pharmaceuticals International Co., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; Drug Safety Research & Evaluation, Takeda Pharmaceuticals International Co., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Arslan+SY%22">Arslan SY</searchLink>; BioAnalysis, Applied Research Management & Biomedical Science (AMS), Astellas Pharma Inc., Northbrook, IL, USA.<br /><searchLink fieldCode="AU" term="%22Yoder+G%22">Yoder G</searchLink>; Aimmune (Nestlé Health Sciences), Brisbane, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ekert+JE%22">Ekert JE</searchLink>; In Vitro In Vivo Translation, Research, Pharmaceutical R&D, GlaxoSmithKline, Collegeville, PA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100953980%22">ALTEX</searchLink> [ALTEX] 2022; Vol. 39 (2), pp. 297–314. <i>Date of Electronic Publication: </i>2022 Jan 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Spektrum+Akademischer+Verlag%22">Spektrum Akademischer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>100953980 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1868-8551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221868596X%22">1868596X </searchLink><i>NLM ISO Abbreviation: </i>ALTEX <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35064273
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.14573/altex.2112203
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 297–314
    Titles:
      – TitleFull: Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Baran SW
      – PersonEntity:
          Name:
            NameFull: Brown PC
      – PersonEntity:
          Name:
            NameFull: Baudy AR
      – PersonEntity:
          Name:
            NameFull: Fitzpatrick SC
      – PersonEntity:
          Name:
            NameFull: Frantz C
      – PersonEntity:
          Name:
            NameFull: Fullerton A
      – PersonEntity:
          Name:
            NameFull: Gan J
      – PersonEntity:
          Name:
            NameFull: Hardwick RN
      – PersonEntity:
          Name:
            NameFull: Hillgren KM
      – PersonEntity:
          Name:
            NameFull: Kopec AK
      – PersonEntity:
          Name:
            NameFull: Liras JL
      – PersonEntity:
          Name:
            NameFull: Mendrick DL
      – PersonEntity:
          Name:
            NameFull: Nagao R
      – PersonEntity:
          Name:
            NameFull: Proctor WR
      – PersonEntity:
          Name:
            NameFull: Ramsden D
      – PersonEntity:
          Name:
            NameFull: Ribeiro AJS
      – PersonEntity:
          Name:
            NameFull: Stresser D
      – PersonEntity:
          Name:
            NameFull: Sung KE
      – PersonEntity:
          Name:
            NameFull: Sura R
      – PersonEntity:
          Name:
            NameFull: Tetsuka K
      – PersonEntity:
          Name:
            NameFull: Tomlinson L
      – PersonEntity:
          Name:
            NameFull: Van Vleet T
      – PersonEntity:
          Name:
            NameFull: Wagoner MP
      – PersonEntity:
          Name:
            NameFull: Wang Q
      – PersonEntity:
          Name:
            NameFull: Arslan SY
      – PersonEntity:
          Name:
            NameFull: Yoder G
      – PersonEntity:
          Name:
            NameFull: Ekert JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1868-8551
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: ALTEX
              Type: main
ResultId 1